位置:首页 > 蛋白库 > ADCY7_BOVIN
ADCY7_BOVIN
ID   ADCY7_BOVIN             Reviewed;        1078 AA.
AC   Q29450; O02856;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   03-AUG-2022, entry version 145.
DE   RecName: Full=Adenylate cyclase type 7 {ECO:0000250|UniProtKB:P51828};
DE            EC=4.6.1.1;
DE   AltName: Full=ATP pyrophosphate-lyase 7;
DE   AltName: Full=Adenylate cyclase type VII;
DE   AltName: Full=Adenylyl cyclase 7;
GN   Name=ADCY7 {ECO:0000250|UniProtKB:P51828};
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Retina;
RX   PubMed=8557110; DOI=10.1016/0014-5793(95)01470-5;
RA   Voelkel H., Beitz E., Klumpp S., Schultz J.E.;
RT   "Cloning and expression of a bovine adenylyl cyclase type VII specific to
RT   the retinal pigment epithelium.";
RL   FEBS Lett. 378:245-249(1996).
CC   -!- FUNCTION: Catalyzes the formation of cAMP in response to activation of
CC       G protein-coupled receptors. Functions in signaling cascades activated
CC       namely by thrombin and sphingosine 1-phosphate and mediates regulation
CC       of cAMP synthesis through synergistic action of the stimulatory G alpha
CC       protein with GNA13 (By similarity). Also, during inflammation, mediates
CC       zymosan-induced increase intracellular cAMP, leading to protein kinase
CC       A pathway activation in order to modulate innate immune responses
CC       through heterotrimeric G proteins G(12/13) (By similarity). Functions
CC       in signaling cascades activated namely by dopamine and C5 alpha chain
CC       and mediates regulation of cAMP synthesis through synergistic action of
CC       the stimulatory G protein with G beta:gamma complex (By similarity).
CC       Functions, through cAMP response regulation, to keep inflammation under
CC       control during bacterial infection by sensing the presence of serum
CC       factors, such as the bioactive lysophospholipid (LPA) that regulate
CC       LPS-induced TNF-alpha production. However, it is also required for the
CC       optimal functions of B and T cells during adaptive immune responses by
CC       regulating cAMP synthesis in both B and T cells (By similarity).
CC       {ECO:0000250|UniProtKB:P51828, ECO:0000250|UniProtKB:P51829}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP = 3',5'-cyclic AMP + diphosphate; Xref=Rhea:RHEA:15389,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58165; EC=4.6.1.1;
CC         Evidence={ECO:0000250|UniProtKB:P51828};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P30803};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:P30803};
CC       Note=Binds 2 magnesium ions per subunit. Is also active with manganese
CC       (in vitro). {ECO:0000250|UniProtKB:P30803};
CC   -!- ACTIVITY REGULATION: Activated by the G protein alpha subunit.
CC       Activated by the G protein beta and gamma subunit complex. Activated by
CC       GNA13 and GNA12. Ethanol and phorbol 12,13-dibutanoate significantly
CC       potentiate adenylate cyclase activity generated in response to the
CC       activation of the prostanoid receptor by the agonist prostaglandin
CC       E1(1-) in a PKC-dependent manner (By similarity). Inhibited by lithium
CC       (By similarity). {ECO:0000250|UniProtKB:P51828,
CC       ECO:0000250|UniProtKB:P51829}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Found exclusively in the retinal pigment
CC       epithelium.
CC   -!- DOMAIN: The protein contains two modules with six transmembrane helices
CC       each; both are required for catalytic activity. Isolated N-terminal or
CC       C-terminal guanylate cyclase domains have no catalytic activity, but
CC       when they are brought together, enzyme activity is restored. The active
CC       site is at the interface of the two domains. Both contribute substrate-
CC       binding residues, but the catalytic metal ions are bound exclusively
CC       via the N-terminal guanylate cyclase domain.
CC       {ECO:0000250|UniProtKB:P26769}.
CC   -!- PTM: Phosphorylated by PRKCD. {ECO:0000250|UniProtKB:P51828}.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl cyclase
CC       family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA89894.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z49806; CAA89894.1; ALT_INIT; mRNA.
DR   RefSeq; NP_776655.1; NM_174230.2.
DR   RefSeq; XP_005218501.1; XM_005218444.3.
DR   AlphaFoldDB; Q29450; -.
DR   SMR; Q29450; -.
DR   STRING; 9913.ENSBTAP00000008153; -.
DR   PaxDb; Q29450; -.
DR   GeneID; 281603; -.
DR   KEGG; bta:281603; -.
DR   CTD; 113; -.
DR   eggNOG; KOG3619; Eukaryota.
DR   HOGENOM; CLU_001072_2_5_1; -.
DR   InParanoid; Q29450; -.
DR   OrthoDB; 363718at2759; -.
DR   TreeFam; TF313845; -.
DR   Proteomes; UP000009136; Unplaced.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0004016; F:adenylate cyclase activity; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0006171; P:cAMP biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0071361; P:cellular response to ethanol; ISS:UniProtKB.
DR   GO; GO:0071285; P:cellular response to lithium ion; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:1900016; P:negative regulation of cytokine production involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0002819; P:regulation of adaptive immune response; ISS:UniProtKB.
DR   CDD; cd07302; CHD; 2.
DR   Gene3D; 3.30.70.1230; -; 2.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR032628; AC_N.
DR   InterPro; IPR030672; Adcy.
DR   InterPro; IPR009398; Adcy_conserved_dom.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   Pfam; PF16214; AC_N; 1.
DR   Pfam; PF06327; DUF1053; 1.
DR   Pfam; PF00211; Guanylate_cyc; 2.
DR   PIRSF; PIRSF039050; Ade_cyc; 1.
DR   SMART; SM00044; CYCc; 2.
DR   SUPFAM; SSF55073; SSF55073; 2.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 2.
PE   2: Evidence at transcript level;
KW   ATP-binding; cAMP biosynthesis; Glycoprotein; Lyase; Magnesium; Manganese;
KW   Membrane; Metal-binding; Nucleotide-binding; Reference proteome; Repeat;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..1078
FT                   /note="Adenylate cyclase type 7"
FT                   /id="PRO_0000195702"
FT   TOPO_DOM        1..33
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        34..54
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        63..83
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        95..120
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        125..145
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        150..170
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        176..196
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        197..594
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        595..615
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        620..640
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        669..688
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        718..737
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        746..773
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        792..812
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        813..1078
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          455..476
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          477..482
FT                   /note="Mediates regulation of adenylate cyclase activity by
FT                   C5 alpha-induced G- beta and gamma pathway"
FT                   /evidence="ECO:0000250|UniProtKB:P51828"
FT   REGION          491..499
FT                   /note="Mediates regulation of adenylate cyclase activity by
FT                   sphingosine 1-phosphate-induced G alpha 13 pathway"
FT                   /evidence="ECO:0000250|UniProtKB:P51828"
FT   REGION          502..545
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          506..584
FT                   /note="Modulates adenylate cyclase activity by modulating
FT                   the binding of G(s)alpha to the high-affinity G(s)alpha
FT                   binding site in 7C1a/7C2"
FT                   /evidence="ECO:0000250|UniProtKB:P51828"
FT   COMPBIAS        455..475
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        526..545
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         284..289
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P30803"
FT   BINDING         284
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         284
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         285
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         326..328
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P30803"
FT   BINDING         328
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         328
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         372
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P30803"
FT   BINDING         929
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   BINDING         1008..1010
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   BINDING         1015..1019
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   BINDING         1055
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   CARBOHYD        701
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        776
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        781
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   1078 AA;  120820 MW;  50E89BF08E37FCBB CRC64;
     MPAKGRYFLN EGEEGPDQDA LYEKYRLTSQ HGPLLLMLLL VAIAACTTLI VITFSYGDPS
     RHRAVLGTAF FTLAMFVLLY ALVYVECLDR RGLRISALLI WGCLVTLGYV LVFDFDSPRK
     DTLCLWGRCP SSSFVVFVVY TLLPFSMWGA VTAGLVSSIS HLLVLAMHQE DFTSPVGLKL
     LATAVVFVCG NLTGAFHKHH MQDASHDLFT YTVKCIQIRR KLRIEKRQQE NLLLSVLPAH
     ISMGMKLAII ERLKERGDRR YLPDNNFHNL YVKRHQNVSI LYADIVGFTR LASDCSPKEL
     VVVLNELFGK FDQIAKANEC MRIKILGDCY YCVSGLPVSL PNHARNCVKM GLDMCEAIKQ
     VREATGVDIS MRVGIHSGNV LCGVIGLRKW QYDVWSHDVS LANRMEAAGV PGRVHITEAT
     LKHLDKAYEV EDGHGQQRDP YLKEMNIRTY LVIDPRSQQP PQPSQHNSKN KGNATLKMRA
     SVRMTRYLES WGAARPFAHL NQRESVSSSE TLVSHGRRPK AVPLRRHRTP DRSASPKGRS
     EDDSYDDEML SAIEGLSSTR PCCSKSDDFS TFGSIFLEKG FEREYRLAPI PRVRYYFACA
     SLVFVCILLI HVLLLYSMKT LGVSFGLVAC VLGLVLGLCF ADVFLRCCPA LGKLRAIAES
     VETQPLLRVS LAILTIGSLL VIAVVNLPLM PFRDRGLTAG NETGLRAVSG WEMSPCYLLP
     YYTCSCILAF IACSVFLRMS LELKVVLLTV ALVAYLVLFN VYPSWQWDCC GHSLGNLTGT
     NGTLSSSSCS WHLKTMTNFY LVLFYTTLIM LSRQIDYYCR LDCLWKKKFK KEHEEFETME
     NVNRLLLENV LPAHVAAHFI GDKLNEDWYH QSYDCVCVMF ASVPDFKVFY TECDVNKEGL
     ECLRLLNEII ADFDELLLKP KFSGVEKIKT IGSTYMAAAG LSVPSGPENQ DLERQHAHIG
     IMVEFSTALM SKLDGINRHS FNSFRLRVGI NHGPVIAGVI GARKPQYDIW GNTVNVASRM
     ESTGELGKIQ VTEETCTILQ GLGYSCECRG LIDVKGKGEL RTYFVCTDTA KFQGLGLN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025